The global virus filtration market size is expected to reach USD 7.0 billion by 2026, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 12.7% during the forecast period. Increasing demand for biological products such as vaccines, therapeutic proteins, blood and blood products, cellular and gene therapy, tissue, and stem cell products is a major factor driving the growth. Biopharmaceuticals are mainly derived from human, animal, and plants and therefore require a scrutinized virus filtration procedure to avoid virus contamination in the production. Therefore, the necessity of this procedure during the production of biologics is expected to boost the market growth.
Many leading biopharmaceuticals and biotechnology manufacturers are involved in R&D to develop innovative biological products. For instance, in 2016, Pfizer Inc. invested USD 7,872.0 million in R&D, which was around 8% more than the R&D investment in 2015. This investment was mainly made to boost innovation and productivity in R&D to accomplish a sustainable pipeline of vaccines and differentiated therapies with lucrative commercial opportunities. Virus filtration is an important step in biologics development, thus, increasing R&D on biologics is expected to drive the product demand.
Browse full report with Table of Content @ https://www.grandviewresearch.com/industry-analysis/virus-filtration-market
Virus Filtration Market Report Highlights
• Consumables was the largest revenue generating segment in 2018 owing to the increased usage of consumables including reagents, kits, and membranes in biologics downstream processing
• Chromatography technology segment is projected to expand at the fastest CAGR during the forecast period, owing to advancements such as disposable or single-use membranes that eliminate the risk of a potential virus contaminant
• Biologicals segment held the largest market share in 2018 and is projected to maintain its dominance during the forecast period due to rising prevalence of chronic diseases such as cancer, blood disorders, and diabetes
• The biotechnology and biopharmaceutical companies segment is projected to expand at the fastest CAGR over the forecast period owing to increasing investment in R&D and production of biologics
• North America led the virus filtration market in 2018 primarily due to the presence of several leading biotechnology companies and increased R&D activities
• Asia Pacific is estimated to expand at the highest CAGR during the forecast period. Growing presence of CROs in countries including China and India due to the presence of a large genome pool, less stringent regulations, and availability of economical labor force is contributing to the regional growth
• Some of the major players are Merck KGaA; Sartorius; Danaher; Thermo Fisher Scientific, Inc.; Charles River Laboratories International, Inc.; GE Healthcare; Asahi Kasei Medical Co., Ltd.; WuXi PharmaTech (Cayman) Inc.; Lonza; and Clean Cells
For Requesting a Sample Copy of This Report, Please Visit @ https://www.grandviewresearch.com/industry-analysis/virus-filtration-market/request/rs1
Virus Filtration Market Segmentation
Grand View Research has segmented the global virus filtration market on the basis of product, technology, application, end use, and region:
Virus Filtration Product Outlook (Revenue, USD Million, 2015 - 2026)
• Consumables
• Kits and reagents
• Others
• Instruments
• Filtration systems
• Chromatography systems
• Services
Virus Filtration Technology Outlook (Revenue, USD Million, 2015 - 2026)
• Filtration
• Consumables
• Instruments
• Services
• Chromatography
• Consumables
• Instruments
• Services
Virus Filtration Application Outlook (Revenue, USD Million, 2015 - 2026)
• Biologicals
• Vaccines and therapeutics
• Blood and blood products
• Cellular and gene therapy products
• Tissue and tissue products
• Stem cell products
• Medical devices
• Water purification
• Air purification
Virus Filtration End Use Outlook (Revenue, USD Million, 2015 - 2026)
• Biopharmaceutical & biotechnology companies
• Contract research organizations
• Medical devices companies
• Academic institutes & research laboratories
Virus Filtration Regional Outlook (Revenue, USD Million, 2015 - 2026)
• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• Spain
• Italy
• France
• Russia
• Asia Pacific
• China
• India
• Japan
• Singapore
• Australia
• South Korea
• Latin America
• Brazil
• Mexico
• Argentina
• Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
Inquire more or share questions if any before the purchase on this report @ https://www.grandviewresearch.com/inquiry/4336/ibb
Browse More Related Report:
Pharmaceutical Filtration Market Size, Share & Trends Analysis Report By Product (Membrane Filters, Pre-filters & Depth Media, Cartridges & Capsules), By Technique, By Application, By Scale Of Operation, And Segment Forecasts, 2018 - 2025
About Grand View Research
Grand View Research is a market research and consulting company registered in the State of California having its headquarters in San Francisco. The company offers syndicated research reports, customized research reports, and consulting services. With Grand View Research, you get an opportunity to understand market trends, insights, and business statistics from a strategic standpoint. With a deep-seated understanding of many business environments, Grand View Research offers business and market intelligence studies and accomplishes more than 300 multi-country market studies.
Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist - U.S.A.
Email: Send Email
Phone: 1888202951
Address:Grand View Research, Inc. 201 Spear Street 1100 San Francisco, CA 94105, United States
City: San Francisco
State: California
Country: United States
Website: https://www.grandviewresearch.com/industry-analysis/virus-filtration-market
